73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New lease on life for two lung cancer patients after pioneering double-lung transplant

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S
Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy
Drug combination shows potential in aggressive leukemia

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in
Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient
Exploiting the synergy of nutraceuticals for cancer prevention and treatment

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including
Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January
New hope for kidney cancer treatment using existing drugs

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena
Finding molecular secrets hidden in premature aging diseases and cancer using AI

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in
Using spatial single-cell transcriptomics to visualize diffuse midline glioma

Using spatial single-cell transcriptomics to visualize diffuse midline glioma

byChildren's Hospital BostonH3-K27M DMG cohort profiled by single-cell multi-omics. a, Schematic of the workflow. b, Clinico-molecular cohort characteristics. The upper legend bars depict th

Using spatial single-cell transcriptomics to visualize diffuse midline glioma

byChildren's Hospital BostonH3-K27M DMG cohort profiled by single-cell multi-omics. a, Schematic of the workflow. b, Clinico-molecular cohort characteristics. The upper legend bars depict th
Tackling resistance to HIF2 drugs with an RNA-based therapy

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca
Fighting cancer on Earth and in space using high-energy protons

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph
Using low-intensity continuous ultrasound to inhibit cancer cell migration

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d